Trials / Completed
CompletedNCT05402644
Hepatectomy for Early-stage HCC Patients With CSPH
Clinically Significant Portal Hypertension (CSPH) on Early-stage HCC Following Hepatectomy: What's the Impact?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 320 (actual)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Clinically significant portal hypertension (CSPH) can affect the surgical prognosis of early-stage (BCLC stage A) HCC. An additional stage, such as the BCLC stage A-B, can be considered.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | hepatectomy | Liver resection |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2017-01-01
- Completion
- 2022-01-01
- First posted
- 2022-06-02
- Last updated
- 2022-06-02
Source: ClinicalTrials.gov record NCT05402644. Inclusion in this directory is not an endorsement.